In partnership with INSERM, Institut Curie and Institut Gustave Roussy, financed by the INCa, we are collaborating to an epidemiologic study of the mid- and long –term effect of ionizing radiation. Called Second Cancer, this investigation aims at correlating radio-induced cancers with the treatments initially applied, in order to better optimize protocols.
DOSIsoft specifically focuses on the radiation dose received by the patient organs and limbs outside of the field of the beam.
|
|
|
Second cancer 
